Terug
Ook genoteerd als
EVOTF
OTC
Dagbereik
€ 2,38
€ 2,46
52-Weeksbereik
€ 2,31
€ 4,80
Volume
82.944
50D / 200D Gem.
€ 3,33
/
€ 3,58
Vorige Slotkoers
€ 2,43
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,3 | 0,4 |
| P/B | 0,9 | 2,9 |
| ROE % | -18,9 | 3,7 |
| Net Margin % | -24,6 | 3,9 |
| Rev Growth 5Y % | 12,3 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Hold
€ 7,00
+194.1%
Forward WPA
-€ 0,16
Omzet Sch.
790 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,23
€ 0,22 – € 0,26
|
960 M | 1 |
| FY2028 |
€ 0,14
€ 0,13 – € 0,16
|
900 M | 1 |
| FY2027 |
€ 0,02
€ 0,02 – € 0,02
|
860 M | 1 |
Belangrijkste Punten
Revenue grew 12,31% annually over 5 years — strong growth
Debt/Equity of 0,47 — conservative balance sheet
Negative free cash flow of -114,02M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,32%
Groei
Revenue Growth (5Y)
12,31%
Revenue (1Y)1,99%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-18,92%
ROIC-7,66%
Net Margin-24,60%
Op. Margin-17,88%
Veiligheid
Debt / Equity
0,47
Current Ratio1,98
Interest Coverage-12,18
Waardering
P/E Ratio
-4,31
P/B Ratio0,89
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,99% | Revenue Growth (3Y) | 2,98% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 796,97M | Net Income (TTM) | -196,08M |
| ROE | -18,92% | ROA | -10,25% |
| Gross Margin | 14,41% | Operating Margin | -17,88% |
| Net Margin | -24,60% | Free Cash Flow (TTM) | -114,02M |
| ROIC | -7,66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,47 | Current Ratio | 1,98 |
| Interest Coverage | -12,18 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,31 | P/B Ratio | 0,89 |
| P/S Ratio | 1,06 | PEG Ratio | -0,05 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 845,90M | Enterprise Value | 983,05M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 796,97M | 781,43M | 751,45M | 618,03M | 500,92M |
| Net Income | -196,08M | -83,91M | -175,66M | 215,51M | 6,28M |
| EPS (Diluted) | -0,56 | -0,23 | -0,49 | 0,65 | 0,02 |
| Gross Profit | 114,88M | 175,05M | 174,07M | 151,54M | 125,74M |
| Operating Income | -142,52M | -47,51M | 20,85M | 41,00M | 48,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,91B | 2,25B | 2,26B | 2,24B | 1,84B |
| Total Liabilities | 959,98M | 1,13B | 1,07B | 857,48M | 951,26M |
| Shareholders' Equity | 952,53M | 1,12B | 1,19B | 1,38B | 886,41M |
| Total Debt | 443,54M | 815,35M | 506,67M | 512,92M | 601,94M |
| Cash & Equivalents | 306,39M | 510,91M | 400,70M | 699,33M | 517,05M |
| Current Assets | 681,96M | 903,16M | 1,07B | 1,10B | 806,13M |
| Current Liabilities | 344,59M | 464,57M | 337,71M | 324,52M | 255,06M |